DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients

By Kawate Takahiko  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 51-59

Springer Publishing Company

Access to resources Recommend Favorite

Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 775-780

Science Publishers

Access to resources Recommend Favorite

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer

By                

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 663-668

Spandidos Publications

Access to resources Recommend Favorite

Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer

By                            

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 83-89

Spandidos Publications

Access to resources Recommend Favorite

Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

By Rocca Andrea   Viale Giuseppe   Gelber Richard   Bottiglieri Luca   Gelber Shari   Pruneri Giancarlo   Ghisini Raffaella   Balduzzi Alessandra   Pietri Elisabetta   D’Alessandro Claudia   Goldhirsch Aron   Colleoni Marco  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 965-971

Springer Publishing Company

Access to resources Recommend Favorite